Feb 3 (Reuters) - AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an ...

Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon ...

The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...

Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

The FDA delays approval AstraZeneca lupus drug Saphnelo for subcutaneous use, pending additional data; intravenous form remains available globally.

The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough ...

The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...

Add Yahoo as a preferred source to see more of our stories on Google. For many women living with lupus, the hardest part of the disease isn’t learning the diagnosis, it’s learning how much suffering ...

Upper Limb Dysfunction Linked to Poor Quality of Life in SLE In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to ...

Keisha Jordan, a Chicago-born artist transformed her lupus experience into visual art, wallpaper and a documentary to educate ...